HOME > VC DEALS > Revalia Bio
Deal IconDeal

Revalia Bio

Revalia Bio raises $14.5 million seed

Revalia Bio, a New Haven, Connecticut-based biotech company revolutionizing drug development with human data trials, raised $14.5 million in a seed fundraising round led by America’s Frontier Fund with participation from Sierra Ventures, Roger Ferguson, and others.

More on Crunchbase News →


ADVERTISEMENT carta_vcd_page_OCFO

Similar Health deals

The VC Industry's trusted resource

Stay informed on industry shifts, deal trends, and career opportunities in venture capital.

Jobs